Literature DB >> 7729643

Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats.

P L Hickey1, P W Angus, A J McLean, D J Morgan.   

Abstract

BACKGROUND/AIMS: Capillarization associated with hepatic fibrosis may present a functional barrier to oxygen diffusion into the hepatocyte, and restriction on cellular oxygen supply may represent the rate-limiting constraint on hepatic oxidative drug metabolism. The aim of this study was to test this hypothesis by examining the effect of oxygen supplementation on plasma theophylline clearance in 10 control and 10 cirrhotic rats.
METHODS: Theophylline (3 mg/kg) was administered intravenously on two separate occasions, 24 hours apart, during which time the rats breathed either room air or oxygen (95%) from 1 hour before dosing until the end of plasma sampling with a randomized order of gas exposure.
RESULTS: Theophylline clearance was significantly reduced by a mean of 37% (n = 10; P = 0.003) in cirrhotic rats compared with controls. Oxygen supplementation significantly improved plasma theophylline clearance in cirrhotic rats by a mean of 40% (n = 10; P = 0.007), whereas clearance remained unchanged in healthy rats. Clearance in oxygen-supplemented cirrhotic rats was not significantly different from that in controls (P > 0.05).
CONCLUSIONS: These novel findings indicate an important role for hepatic oxygenation in improving drug disposition in cirrhosis, which may have potentially important clinical implications for the management of this disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7729643     DOI: 10.1016/0016-5085(95)90700-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.

Authors:  David G Le Couteur; Robin Fraser; Sarah Hilmer; Laurent P Rivory; Allan J McLean
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.

Authors:  Andrew H Talal; Charles S Venuto; Islam Younis
Journal:  Clin Pharmacol Drug Dev       Date:  2017-03

3.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

4.  Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test.

Authors:  Michael Haimerl; Irene Fuhrmann; Stefanie Poelsterl; Claudia Fellner; Marcel D Nickel; Kilian Weigand; Marc H Dahlke; Niklas Verloh; Christian Stroszczynski; Philipp Wiggermann
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

5.  The effects of codon usage on the formation of secondary structures of nucleocapsid protein of peste des petits ruminants virus.

Authors:  Xiao-Xia Ma; Yi-Ning Wang; Xiao-An Cao; Xue-Rui Li; Yong-Sheng Liu; Jian-Hua Zhou; Xue-Peng Cai
Journal:  Genes Genomics       Date:  2018-05-31       Impact factor: 1.839

Review 6.  Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.

Authors:  D J Morgan; A J McLean
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

Review 7.  Pharmacokinetic drug interactions in liver disease: An update.

Authors:  Pietro Palatini; Sara De Martin
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 8.  The Endothelium as a Driver of Liver Fibrosis and Regeneration.

Authors:  Erica Lafoz; Maria Ruart; Aina Anton; Anna Oncins; Virginia Hernández-Gea
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.